Veterinary Surgical Oncology. Группа авторов

tomography software. Am J Vet Res 77(6):620–626.

      374 Terry, J.L., M. Milovancev, S. Nemanic, et al. 2017. Quantification of surgical margin length changes after excision of feline injection site sarcomas‐A pilot study. Vet Surg 46(2):189–196.

      375 Thamm, D.H., E.A. Mauldin, and D.M. Vail. 1999. Prednisone and vinblastine chemotherapy for canine mast cell tumor – 41 cases (1992–1997). J Vet Intern Med 13(5):491–497.

      376 Thamm, D.H., M.M. Turek, and D.M. Vail. 2006. Outcome and prognostic factors following adjuvant prednisone/vinblastine chemotherapy for high‐risk canine mast cell tumor: 61 cases. J Vet Med Sci 68(6):581–587.

      377 Theilen, G.H. and B.R. Madewell. 1979. Veterinary Cancer Medicine. Philadelphia: Lea & Febiger.

      378 Thompson, J.J., D.L. Pearl, J.A. Yager, et al. 2011. Canine subcutaneous mast cell tumor: Characterization and prognostic indices. Vet Pathol 48(1):156–168.

      379 Thongtharb, A., J.K. Chambers, K. Uchida et al. 2015. Lymphangiosarcoma with systemic metastases in a Japanese domestic cat. J Vet Med Sci 77(3):371–374.

      380 Thornton, K. 2008. Chemotherapeutic management of soft tissue sarcoma. Surg Clin North Am 88(3):647–660, viii.

      381 Torrigiani, F., A. Pierini, R. Lowe, et al. 2019. Soft tissue sarcoma in dogs: A treatment review and a novel approach using electrochemotherapy in a case series. Vet Comp Oncol 17:234–241.

      382 Trappler, M.C., C.A. Popovitch, M.H. Goldschmidt, et al. 2014. Scrotal tumors in dogs: A retrospective study of 676 cases (1986–2010). Can Vet J 55(1):1229–1233.

      383 Trout, N.J., M.M. Pavletic, and K.H. Kraus. 1995. Partial scapulectomy for management of sarcomas in three dogs and two cats. J Am Vet Med Assoc 207(5):585–587.

      384 Tsioli, V., L.G. Papazoglou, N. Papaioannou, et al. 2015. Comparison of three skin‐stretching devices for closing skin defects on the limbs of dogs. J Vet Sci 16:99–106.

      385 Tsuji, N., S. Furukawa, and K. Ozaki. 2013. Cutaneous hemangiosarcoma in a dog. J Toxicol Pathol 26(2):193–195.

      386 Tuohy, J.L., J. Milgram, D.R. Worley, et al. 2009. A review of sentinel lymph node evaluation and the need for its incorporation into veterinary oncology. Vet Comp Oncol7(2):81–91.

      387 Turek, M., R. Gogal Jr, C. Saba, et al. 2014. Masitinib mesylate does not enhance sensitivity to radiation in three feline injection‐site sarcoma cell lines under normal growth conditions. Res Vet Sci 96(2):304–307.

      388 Turrel, J.M., J. Farrelly, R.L. Page, et al. 2006. Evaluation of strontium 90 irradiation in treatment of cutaneous mast cell tumors in cats: 35 cases (1992–2002). J Am Vet Med Assoc 228(6):898–901.

      389 Turrel, J.M., B.E. Kitchell, L.M. Miller, et al. 1988. Prognostic factors for radiation treatment of mast cell tumor in 85 dogs. J Am Vet Med Assoc 193(8):936–940.

      390 Upchurch, D.A., E.E. Klocke, and J.N. Henningson. 2018. Amount of skin shrinkage affecting tumor versus grossly normal marginal skin of dogs for cutaneous mast cell tumors excised with curative intent. Am J Vet Res 79(7):779–786.

      391 Vail, D.M. and S.J. Withrow. 2007. Tumors of the skin and subcutaneous tissues. In Withrow & MacEwen’s Small Animal Clinical Oncology, 4th edition, pp. 375–401. S.J. Withrow and E.G. MacEwen, editors. St. Louis: Saunders Elsevier.

      392 Vail, D., D. Thamm, and J. Liptak. 2019. Withrow and MacEwen’s Small Animal Clinical Oncology. St. Louis: Saunders.

      Vet J

      1 Vascellari, M., E. Melchiotti, E. Bozza et al. 2003. Fibrosarcomas at presumed sites of injection in dogs: Characteristics and comparison with non‐vaccination site sarcomas and feline post‐vaccinal fibrosarcomas. J Vet Med A Physiol Pathol Clin Med 50(6):286–291.

      2 Vascellari, M., E. Melchiotti, and F. Mutinelli. 2006. Fibrosarcoma with typical features of postinjection sarcoma at site of microchip implant in a dog: Histologic and immunohistochemical study. Vet Pathol 43(4):545–548.

      3 Verganti, S., D. Berlato, L. Blackwood, et al. 2017. Use of Oncept melanoma vaccine in 69 canine oral malignant melanomas in the UK. J Small Anim Pract 58(1):10–16.

      4 Vickery, K.R., H. Wilson, D.M. Vail, et al. 2008. Dose‐escalating vinblastine for the treatment of canine mast cell tumor. Vet Comp Oncol 6(2):111–119.

      5 Villamil, J.A., C.J. Henry, and J.N. Bryan. 2011. Identification of the most common cutaneous neoplasms in dogs and evaluation of breed and age distributions for selected neoplasms. J Am Vet Med Assoc 239(7):960–965.

      6 Villamill, J.A., C.J.Henry, J.N. Bryan, et al. 2011. Identification of the most common cutaneous neoplasms in dogs and evaluation of breed and age distributions for selected neoplasms. J Am Vet Med Assoc 239(7):960–965.

      7 Villedieu, E.J., A.F. Petite, J.D. Godolphin, et al. 2021. Prevalence of pulmonary nodules suggestive of metastasis at presentation in dogs with cutaneous or subcutaneous soft tissue sarcoma. J Am Vet Med Assoc 258:179–185.

      8 Ward, H., L.E. Fox, M.B. Calderwood‐Mays, et al. 1994. Cutaneous hemangiosarcoma in 25 dogs: A retrospective study. J Vet Intern Med 8(5):345–348.

      9 Warland, J., I. Amores‐Fuster, W. Newbury, et al. 2014. The utility of staging in canine mast cell tumours. Vet Comp Oncol 12(4):287–298.

      10 Weishaar, K.M., D.H. Thamm, D.R. Worley, et al. 2014. Correlation of nodal mast cells with clinical outcome in dogs with mast cell tumour and a proposed classification system for the evaluation of node metastasis. J Comp Pathol 151(4):329–338.

      11 Weishaar, K.M., E.J. Ehrhart, A.C. Avery, et al. 2018. c‐Kit mutation and localization status as response predictors in mast cell tumors in dogs treated with prednisone and toceranib or vinblastine. J Vet Intern Med 32(1):394–405.

      12 Weisse, C., F.S. Shofer, and K. Sorenmo. 2002. Recurrence rates and sites for grade II canine cutaneous mast cell tumors following complete surgical excision. J Am Anim Hosp Assoc 38(1):71–73.

      13 Williams, J.H. 2005. Lymphangiosarcoma of dogs: A review. J S Afr Vet Assoc 76(3):127–131.

      14 Worley, D.R. 2014. Incorporation of sentinel lymph node mapping in dogs with mast cell tumours: 20 consecutive procedures. Vet Comp Oncol 12(3):215–226.

      15 Zardo, K.M., L.P. Damiani, J.M. Matera, et al. 2016. Recurrent and non‐recurrent feline injection‐site sarcoma: Computed tomographic and ultrasonographic findings. J Feline Med Surg 18(10):773–782.